Nova Mentis Life Science Corp (NOVA.CX)
0.02
+0.01
(+100.00%)
CAD |
CNSX |
May 31, 16:00
Nova Mentis Life Science Enterprise Value: 2.919M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 2.919M |
| May 30, 2024 | 1.447M |
| May 29, 2024 | 2.183M |
| May 28, 2024 | 2.183M |
| May 27, 2024 | 2.183M |
| May 24, 2024 | 2.183M |
| May 23, 2024 | 2.183M |
| May 22, 2024 | 2.183M |
| May 21, 2024 | 2.183M |
| May 17, 2024 | 2.183M |
| May 16, 2024 | 2.183M |
| May 15, 2024 | 1.447M |
| May 14, 2024 | 2.183M |
| May 13, 2024 | 2.183M |
| May 10, 2024 | 1.447M |
| May 09, 2024 | 1.447M |
| May 08, 2024 | 1.447M |
| May 07, 2024 | 2.183M |
| May 06, 2024 | 2.183M |
| May 03, 2024 | 2.183M |
| May 02, 2024 | 2.183M |
| May 01, 2024 | 2.183M |
| April 30, 2024 | 2.183M |
| April 29, 2024 | 2.183M |
| April 26, 2024 | 2.183M |
| Date | Value |
|---|---|
| April 25, 2024 | 2.183M |
| April 24, 2024 | 2.183M |
| April 23, 2024 | 2.183M |
| April 22, 2024 | 1.447M |
| April 19, 2024 | 1.447M |
| April 18, 2024 | 1.447M |
| April 17, 2024 | 1.447M |
| April 16, 2024 | 1.447M |
| April 15, 2024 | 1.447M |
| April 12, 2024 | 2.183M |
| April 11, 2024 | 2.183M |
| April 10, 2024 | 2.183M |
| April 09, 2024 | 2.919M |
| April 08, 2024 | 2.919M |
| April 05, 2024 | 2.183M |
| April 04, 2024 | 2.183M |
| April 03, 2024 | 2.183M |
| April 02, 2024 | 2.183M |
| April 01, 2024 | 2.183M |
| March 28, 2024 | 2.183M |
| March 27, 2024 | 2.183M |
| March 26, 2024 | 2.183M |
| March 25, 2024 | 2.183M |
| March 22, 2024 | 2.183M |
| March 21, 2024 | 2.183M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.447M
Minimum
Apr 15 2024
31.20M
Maximum
Jan 07 2021
7.925M
Average
7.240M
Median
Apr 04 2023
Enterprise Value Benchmarks
| Biocure Technology Inc | 1.450M |
| Core One Labs Inc | 8.573M |
| Nanosphere Health Sciences Inc | 0.2959M |
| Lobe Sciences Ltd | 3.658M |
| Algernon Pharmaceuticals Inc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.1841M |
| Revenue (Quarterly) | 0.0283M |
| Total Expenses (Quarterly) | 0.219M |
| EPS Diluted (Quarterly) | -0.0013 |
| Profit Margin (Quarterly) | -649.3% |
| Earnings Yield | -88.54% |
| Normalized Earnings Yield | -61.92 |